Argon laser trabeculoplasty in triamcinolone acetonide induced ocular hypertension refractory to maximal medical treatment

F. Ricci, Filippo Missiroli, M. Parravano

Research output: Contribution to journalArticle

Abstract

PURPOSE. To report two cases of intraocular hypertension after intravitreal injection of triamcinolone acetonide (iTAA) that were refractory to maximal medical therapy and were successfully treated with argon laser trabeculoplasty (ALT). METHODS. Two patients with history of primary open angle glaucoma were treated with intravitreal injection of triamcinolone acetonide for chronic macular edema secondary to branch retinal vein occlusion. Both patients (Case 1 after 2 months and Case 2 after 5 days) developed intraocular hypertension that did not respond to maximal medical therapy. Despite medical therapy, intraocular pressure (IOP) was 45 mmHg in Case 1 and between 34 and 37 mmHg in Case 2. ALT was performed in the inferior 180° angle using the following parameters: 50 μm size, 700 mW, 0.50 sec, 100 spots. RESULTS. In both patients IOP returned to normal level a few days after ALT. CONCLUSIONS. ALT seems to be effective at reducing IOP in patients with intraocular hypertension secondary to iTAA that does not respond to maximal medical treatment.

Original languageEnglish
Pages (from-to)756-757
Number of pages2
JournalEuropean Journal of Ophthalmology
Volume16
Issue number5
Publication statusPublished - Sep 2006

Fingerprint

Triamcinolone Acetonide
Ocular Hypertension
Trabeculectomy
Argon
Lasers
Intraocular Pressure
Intravitreal Injections
Hypertension
Retinal Vein Occlusion
Macular Edema
Therapeutics
Injections

Keywords

  • Argon laser trabeculoplasty
  • Inraocular hypertension
  • Triamcinolone

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Argon laser trabeculoplasty in triamcinolone acetonide induced ocular hypertension refractory to maximal medical treatment. / Ricci, F.; Missiroli, Filippo; Parravano, M.

In: European Journal of Ophthalmology, Vol. 16, No. 5, 09.2006, p. 756-757.

Research output: Contribution to journalArticle

@article{9048e5b37ec34f1e8287425bed05151e,
title = "Argon laser trabeculoplasty in triamcinolone acetonide induced ocular hypertension refractory to maximal medical treatment",
abstract = "PURPOSE. To report two cases of intraocular hypertension after intravitreal injection of triamcinolone acetonide (iTAA) that were refractory to maximal medical therapy and were successfully treated with argon laser trabeculoplasty (ALT). METHODS. Two patients with history of primary open angle glaucoma were treated with intravitreal injection of triamcinolone acetonide for chronic macular edema secondary to branch retinal vein occlusion. Both patients (Case 1 after 2 months and Case 2 after 5 days) developed intraocular hypertension that did not respond to maximal medical therapy. Despite medical therapy, intraocular pressure (IOP) was 45 mmHg in Case 1 and between 34 and 37 mmHg in Case 2. ALT was performed in the inferior 180° angle using the following parameters: 50 μm size, 700 mW, 0.50 sec, 100 spots. RESULTS. In both patients IOP returned to normal level a few days after ALT. CONCLUSIONS. ALT seems to be effective at reducing IOP in patients with intraocular hypertension secondary to iTAA that does not respond to maximal medical treatment.",
keywords = "Argon laser trabeculoplasty, Inraocular hypertension, Triamcinolone",
author = "F. Ricci and Filippo Missiroli and M. Parravano",
year = "2006",
month = "9",
language = "English",
volume = "16",
pages = "756--757",
journal = "European Journal of Ophthalmology",
issn = "1120-6721",
publisher = "Wichtig Publishing",
number = "5",

}

TY - JOUR

T1 - Argon laser trabeculoplasty in triamcinolone acetonide induced ocular hypertension refractory to maximal medical treatment

AU - Ricci, F.

AU - Missiroli, Filippo

AU - Parravano, M.

PY - 2006/9

Y1 - 2006/9

N2 - PURPOSE. To report two cases of intraocular hypertension after intravitreal injection of triamcinolone acetonide (iTAA) that were refractory to maximal medical therapy and were successfully treated with argon laser trabeculoplasty (ALT). METHODS. Two patients with history of primary open angle glaucoma were treated with intravitreal injection of triamcinolone acetonide for chronic macular edema secondary to branch retinal vein occlusion. Both patients (Case 1 after 2 months and Case 2 after 5 days) developed intraocular hypertension that did not respond to maximal medical therapy. Despite medical therapy, intraocular pressure (IOP) was 45 mmHg in Case 1 and between 34 and 37 mmHg in Case 2. ALT was performed in the inferior 180° angle using the following parameters: 50 μm size, 700 mW, 0.50 sec, 100 spots. RESULTS. In both patients IOP returned to normal level a few days after ALT. CONCLUSIONS. ALT seems to be effective at reducing IOP in patients with intraocular hypertension secondary to iTAA that does not respond to maximal medical treatment.

AB - PURPOSE. To report two cases of intraocular hypertension after intravitreal injection of triamcinolone acetonide (iTAA) that were refractory to maximal medical therapy and were successfully treated with argon laser trabeculoplasty (ALT). METHODS. Two patients with history of primary open angle glaucoma were treated with intravitreal injection of triamcinolone acetonide for chronic macular edema secondary to branch retinal vein occlusion. Both patients (Case 1 after 2 months and Case 2 after 5 days) developed intraocular hypertension that did not respond to maximal medical therapy. Despite medical therapy, intraocular pressure (IOP) was 45 mmHg in Case 1 and between 34 and 37 mmHg in Case 2. ALT was performed in the inferior 180° angle using the following parameters: 50 μm size, 700 mW, 0.50 sec, 100 spots. RESULTS. In both patients IOP returned to normal level a few days after ALT. CONCLUSIONS. ALT seems to be effective at reducing IOP in patients with intraocular hypertension secondary to iTAA that does not respond to maximal medical treatment.

KW - Argon laser trabeculoplasty

KW - Inraocular hypertension

KW - Triamcinolone

UR - http://www.scopus.com/inward/record.url?scp=33845312966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845312966&partnerID=8YFLogxK

M3 - Article

C2 - 17061231

AN - SCOPUS:33845312966

VL - 16

SP - 756

EP - 757

JO - European Journal of Ophthalmology

JF - European Journal of Ophthalmology

SN - 1120-6721

IS - 5

ER -